Tobias R. Mett

Dr. Tobias R. Mett


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2020 in European Journal of Plastic Surgery
Verified
Journal Article
Open access
PDF file
TMTobias R. Mett
Tobias R. Mett
PPPeter P. Pfeiler
Peter P. Pfeiler
RLRosalia Luketina
Rosalia Luketina
ABAlperen S. Bingöl
Alperen S. Bingöl
Nicco KrezdornNicco Krezdorn
Nicco Krezdorn
PVPeter M. Vogt
Peter M. Vogt
Background: Many techniques for the surgical treatment of gynaecomastia have been reported to be effective with reasonable limited scar formation. The aim of this study was to develop a grade adopted algorithm for effective and scar sparing techniques in reconstruction of the male breast dependent on aetiology and grading.Methods: Operative techniques, results, rates of revisions and complications were recorded between 2006 and 2018 and results of 164 male patients were analysed, retrospectively. Skin resecting methods have been used in the earlier stage but were later replaced by minimal periareolar incisions and subcutaneous mastectomy. Resections were combined with ultrasound-assisted liposuction up to grade 2b and inferior pedicled breast reduction in 3rd degree gynaecomastias resulting in reduction of scars and effective removal of breast tissue.Results: Retrospective analysis showed that a periareolar mastopexy was used in 24% of patients with gynaecomastia grade I, IIa and IIb to reshape the breast after subcutaneous mastectomy in the early stage of this study from 2006 to 2010. With the established standardised use of ultrasound-assisted liposuction, only 2% of patients required a mastopexy in the following years. In grade 3 gynaecomastia, the classical approach resulting in an inverted t-scar was later abandoned for an approach with a periareolar and submammary scar and inferior dermoglandular flap. The rate of secondary surgery with the used techniques did not increase.Conclusions: When using standardised techniques in reshaping the male breast, an aesthetically pleasing and safe result can be achieved by scar sparing techniques in a safe single-stage procedure.Level of evidence: Level IV, therapeutic study.

1 February 2017 in Burns
Verified
Journal Article
Closed access
Nicco KrezdornNicco Krezdorn
Nicco Krezdorn
SKSören Könneker
Sören Könneker
FPFelix Julian Paprottka
Felix Julian Paprottka
CTChristian Tapking
Christian Tapking
TMTobias R. Mett
Tobias R. Mett
PVPeter M. Vogt
Peter M. Vogt

1 September 2017 in Surgical Oncology
Verified
Journal Article
Closed access
Peter M VogtPeter M Vogt
Peter M Vogt
TMTobias R. Mett
Tobias R. Mett
GBG.F. Broelsch
G.F. Broelsch
CRChristine Radtke
Christine Radtke
NGN.-C. Gellrich
N.-C. Gellrich
RIR. Ipaktchi
R. Ipaktchi

27 March 2023 in BMC Surgery
Verified
Journal Article
Open access
PDF file
TMTobias R. Mett
Tobias R. Mett
SBStephanie Boetger-Bolten
Stephanie Boetger-Bolten
FBFlorian Bucher
Florian Bucher
PVPeter M. Vogt
Peter M. Vogt
Background: Free flap design must fulfill different criteria to ensure functional and aesthetic reconstruction of different types of defects in different body areas. A four-dimensional planning concept was used including flap length, width, thickness and tissue composition. This study evaluates if body-mass-index (BMI) has a predictive value for flap design. Methods: A prospective study including hospitalized patients in the Department of Plastic, Aesthetic, Hand and Reconstructive Surgery was conducted. Not taking into account the reason for admission, the patients were examined based on age, weight, height, BMI and sex. The areas of a potential harvest of free fasciocutaneous and perforator flaps were measured using ultrasound examination to determine the thickness of the subcutaneous layers and prove blood perfusion. Results: Over the period of four months, a total of 101 patients (36 females and 65 males) were included in this study and gave written consent. No statistical significance regarding the demographic data such as age, sex and BMI could be identified. An average to high correlation between free flap thickness and BMI was shown for the thoracodorsal artery perforator (TDAP), anterior lateral thigh (ALT) and deep inferior epigastric perforator (DIEP) flap in both, male and female patients. Free flaps of distal body parts such as the interosseous posterior flap, showed a lower correlation. No correlation using the Pearson coefficient could be found for age and volume. Conclusion: Our study demonstrated that the BMI is a predictive indicator that can be used in the preoperative planning of reconstructions using free flaps. Depending on the defect location, the BMI can be considered to predict the thickness of the free flap and may influence the surgeon’s choice. On the other hand, a lower correlation between BMI and flap thickness encourages the use of standard flaps if more volume is desired, as the DIEP flap might be sufficient even in normal-weight women. Flaps of distal body parts, such as the forearm or lower leg, are not prone to such predictions and require other selection criteria.

1 March 2019 in Plastic and Reconstructive Surgery - Global Open
Verified
Journal Article
Open access
MRMona Rudolph
Mona Rudolph
PVPeter M. Vogt
Peter M. Vogt
KMKlaus Müller
Klaus Müller
TMTobias R. Mett
Tobias R. Mett
Background: Following liposuction, abdominoplasty is the most frequent body-contouring intervention in the world. The transection of small blood vessels in large areas and subsequent bleeding is a viable risk during this procedure. The resulting microvascular bleedings should be stopped thoroughly to reduce the probability of related complications. In this prospective, monocentric, randomized study, the efficacy of the polysaccharide-based hemostat 4DryField PH (4DF) (PlanTec Medical, Lueneburg, Germany) is examined in classic abdominoplasty and lower body lift after Lockwood. Methods: For this prospective, monocentric, randomized study, 40 patients underwent surgery for both interventions. Twenty patients received an abdominoplasty, and 20 patients underwent a body lift. In each group, 10 patients have been treated with 4DF, whereas 10 have been served as the untreated control group. Results: 4DF had neither a beneficial nor a negative effect on necessity of drainages, drainage volume and duration, length of hospital stay or frequency of postoperative seromas, wound healing disturbances, and infections, independent of surgical intervention. Patients in the 4DF group, however, had more individual risk factors, and required extended surgical interventions that might mask primary outcome results. Conclusions: This is the first prospective, monocentric, randomized study on 4DF in body-contouring surgery. The use of 4DF did not lead to a better postoperative outcome regarding hemostasis and lymphostasis. Potential benefits need further evaluation in high-volume studies.

1 September 2022 in Cells
Verified
Journal Article
Open access
PDF file
FSFrederik Schlottmann
Frederik Schlottmann
VBVesna Bucan
Vesna Bucan
SSSarah Strauß
Sarah Strauß
FKFelix Koop
Felix Koop
Peter M VogtPeter M Vogt
Peter M Vogt
TMTobias R. Mett
Tobias R. Mett
Breast carcinoma is one of the most common malignant tumors in women. In cases of hormone-sensitive cells, tamoxifen as an anti-estrogenic substance is a first line medication in the adjuvant setting. The spectrum of autologous breast reconstructions ranges from fat infiltrations to complex microsurgical procedures. The influence of adipose-derived stem cells (ASC) on the tumor bed and a possibly increased recurrence rate as a result are critically discussed. In addition, there is currently no conclusive recommendation regarding tamoxifen-treated patients and autologous fat infiltrations. The aim of the present study was to investigate the effect of tamoxifen on the gene expression of a variety of genes involved in tumorigenesis, cell growth and transformation. Mammary epithelial cell line and mammary carcinoma cell lines were treated with tamoxifen in vitro as well as co-cultured with ASC. Gene expression was quantified by PCR arrays and showed increased expression in the mammary carcinoma cell lines with increasing time of treatment and concentration of tamoxifen. The data presented can be considered as an addition to the controversial discussion on the relationship between ASC and breast carcinoma cells. Further studies are needed to quantify the in vivo interaction of ASC and mammary carcinoma cells and to conclusively assess the impact of tamoxifen in reconstructive cases with fat grafting.